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Abstract
Background: Qi (氣 qì) refers to the vital energy of the body in Traditional Chinese medicines (TCM). Qi deficiency 
(氣虛 qì xū) is the most common symptom in cancer patients according to the concept of TCM. We hypothesized that 
cancer patients with Qi deficiency suffer from poor quality of life (QOL) and fatigue.
Method: Among the 256 registered cancer patients screened at our outpatient clinic, a total of 198 were enrolled. The 
inclusion criteria were (1) age between 18 and 70 years, (2) cancer diagnosis confirmed by the professional physician, 
(3) being Chinese, and (4) Eastern Cooperative Oncology Group (ECOG) performance status rating (PSR) ≤ 3. The 
major outcome is the difference in QOL score in cancer patients with and without Qi deficiency. 
Results: The initial results showed statistically significant differences in WHO-QOL scores in physical, psychological, 
and social domains between the groups with and without Qi deficiency as well as the groups with and without cancer-
related fatigue (CRF).  All patients with CRF present were also diagnosed as Qi deficient.  In addition, among the 
patients with no CRF, 39.9% (69/173) were diagnosed as suffering from Qi deficiency, which led to poor QOL. 
Conclusions: The present study showed statistically significant difference in WHO-QOL scores in physical, 
psychological, and social domains between the groups with and without Qi deficiency as well as the groups with and 
without CRF. Cancer patients diagnosed with Qi deficiency or CRF have poor QOL. The concept of Qi deficiency in 
TCM might be applied to cancer health care.
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Introduction
Complementary and alternative medicines (CAMs), 
in particular herbal medicine and traditional Chinese 
medicine (TCM), are commonly used by cancer 
patients in Chinese-speaking population and Asian 
countries (Hsiao and Liu, 2010; Konkimalla and Efferth, 
2008; Wu et al., 2009). TCM in combination with 
chemotherapy or radiotherapy can enhance the efficacy 
and ameliorate the side effects and complications caused 
by chemotherapy or radiotherapy (Chan et al., 2011; Qi 
et al., 2010). Syndrome differentiation of TCM plays 
a main role in treatment of cancer patients (Seki et al., 
2005; Sun et al., 2010). The impairment of Qi (氣 qì) 
flow within the body is often observed in cancer patients 
who choose TCM as adjuvant treatment (Qi et al., 2010; 
Seki et al., 2005; Sun et al., 2010).
Fatigue is a common symptom or complaint among 
cancer patients (Wagner and Cella, 2004; Kontos and 
Viswanath, 2011; Stasi et al., 2003). Cancer-related 
fatigue (CRF) affects quality of life (QOL) including 
physical, mental and psychosocial aspects (Barsevick 
et al., 2010). Qi refers to the vital energy of the body in 
TCM. It maintains blood circulation, warms the body 
and fights diseases. Qi deficiency (氣虛 qì xū) is the 
most common symptom in cancer patients according 
to the concept of TCM. Many previous reports showed 
that Qi supplementation (補氣 bǔ qì) can help enhance 
the effects of cancer therapy (Chui et al., 2005; Li et 
al., 2007; Qi et al., 2010; Seki et al., 2005; Yan et al., 
2008; Yan et al., 2010); and hence, the main role of 
TCM in cancer therapy is to balance the Qi flow in 
cancer patients. In addition, the QOL of cancer patients 
may be affected by Qi deficiency and CRF. In view of 
the above, we conducted this cross-sectional study to 
explore the relationship between Qi deficiency, CRF and 
QOL in cancer patients.
Materials and Methods
Study design and participants
This was a cross-sectional study conducted from 
January 2010 through December 2010 in Taipei City 
Hospital, Taiwan. Among the 256 registered cancer 
patients screened at our outpatient clinic, a total of 
198 were enrolled. The inclusion criteria were (1) age 
between 18 and 70 years, (2) cancer diagnosis confirmed 
by the professional physician, (3) being Chinese, and 
(4) Eastern Cooperative Oncology Group (ECOG) 
performance status rating (PSR) ≤ 3. The exclusion 
criteria were (1) unconsciousness, (2) delirium and 
psychiatric, (3) complications present, and (4) any 
other conditions not suitable for study as evaluated 
by the physician-in-charge. The major outcome is the 
difference in QOL score in cancer patients with and 
without Qi deficiency.  The protocol was approved by 
the Human Ethics Committee of our hospital. Informed 
consent was obtained from all the enrolled patients. 
Qi deficiency 
TCM practitioners make diagnosis in terms of Yin 
(陰 yīn), Yang (陽 yáng), Qi, Blood, and Organ (器 qì) 
imbalance on the basis of signs and symptoms observed 
by the doctors and reported by the patients. In cancer 
patients, Qi deficiency is the most common symptom. 
However, there are no existing questionnaires or 
diagnostic tools for Qi deficiency.  Hence, we chose 
to use the interview approach, which is a common 
diagnostic method adopted by TCM practitioners. With 
the aim to devise a simple and efficient screening tool, 
nine TCM doctors with clinical experience referred 
to relevant references (Hu et al., 2005; WHO, 2007) 
and developed three yes-no questions for diagnosing 
Qi deficiency among cancer patients according to the 
concept of TCM. The questionnaire designed contained 
the following. 
In the past week, did you often have the following 
symptoms? 
(Often means more than 8 hour per day and more than 
four days per week)
(1) Felt exhausted or lack of energy 
(2)  Did not feel like talking or talked in a low and 
weak voice.
(3)  Did not feel like moving about or did not have the 
strength to walk. 
Cancer patients responding yes to two questions 
or more in the interview would be classified as being 
Qi deficient. Validation test results showed an alpha 
coefficient of 0.89 and Cronbach’s alpha coefficient 
of 0.88, indicating that the questionnaire has good 
reliability.
Cancer-related fatigue
Fatigue caused by cancer or cancer therapy had 
been proposed for recognition by the World Health 
Organization (WHO) and for publication in the 
International Statistical Classification of Diseases 
and Related Health problems (10th revision) (ICD-10) 
(Lesage and Portenoy, 2002). We adopted the criteria 
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of cancer-related fatigue (CRF) in ICD-10, which have 
been validated and recommended as a diagnostic tool 
for CRF (Cella et al., 2001; Van Belle et al., 2005). 
In the ICD-10 criteria for diagnosis of CRF, fatigue 
is defined as present when the patient experienced six 
or more of the 11 symptoms listed. The 11 symptoms 
designed contained the following (Cella et al., 2001). 
Six (or more) of the following symptoms have been 
present every day or nearly every day during the same 
2-week period in the past month, and at least one of the 
symptoms is (A1) significant fatigue.
A1. Significant fatigue, diminished energy, or 
increased need to rest,   disproportionate to any recent 
change in activity level
A2. Complaints of generalized weakness or limb 
heaviness
A3. Diminished concentration or attention
A4. Decreased motivation or interest to engage in 
usual activities
A5. Insomnia or hypersomnia
A6.  Experience of  s leep as  unrefreshing or 
nonrestorative
A7. Perceived need to struggle to overcome inactivity
A8. Marked emotional reactivity (eg, sadness, 
frustration, or irritability) to feeling fatigued
A9. Difficulty completing daily tasks attributed to 
feeling fatigued
A10. Perceived problems with short-term memory
A11. Postexertional malaise lasting several hours
B. The symptoms cause clinically significant distress 
or impairment in social, occupational, or other important 
areas of functioning
C. There is evidence from the history, physical 
examination, or laboratory findings that the symptoms 
are a consequence of cancer or cancer therapy.
D. The symptoms are not primarily a consequence 
of comorbid psychiatric disorders such as major 
depression, somatization disorder, somatoform disorder, 
or delirium.
Quality of Life
To measure the quality of life among our subjects, we 
used the self-administered questionnaire of WHOQoL-
BREF, Taiwan version, which was well validated with 
consistency coefficients ranging from 0.70 to 0.77 
(Yao et al., 2002). The WHOQoL-BREF questionnaire 
evaluated quality of life in physical, psychological, 
social and environmental domains, with scores ranging 
from 0 to 100.  
Outcome measurements
All subjects had to answer questions concerning Qi 
deficiency and CRF in ICD-10 posed by the attending 
physician during the outpatient follow-up session. 
They also had to complete the self-administered 
WHOQoL-BREF, Taiwan version under the assistance 
of the physician-in-charge. Standardized procedures 
for measurement were set up and all participating 
physicians received prior training before the study 
on how to interview the patients and assist them in 
completing the questionnaire. Physical measurements 
were made with subjects in their undergarments with 
a hospital gown on. Height was measured with a wall-
mounted stadiometer to the nearest 0.1 cm, weight was 
measured on a calibrated balance beam scale to the 
nearest 0.1 kg, and BMI was calculated according to 
the formula: BMI = BW / height square (kg/m2). The 
major outcome is the difference in QOL score in cancer 
patients with and without Qi deficiency.
Statistical analysis
The data were analyzed using SPSS software (version 
11.5). Student t-test was employed to examine the main 
outcomes, demographic data, and score of QOL. Chi-
square test was used for comparison between gender 
(male/female) and percentage of positive response 
(yes%) between groups. One-way ANOVA tests were 
employed to examine the means among groups. All p 
values were two-tailed and the α level of significance 
was set at 0.05. 
Results
Demographics and clinical features of cancer patients
Among the 256 registered cancer patients screened 
at our outpatient clinic, a total of 198 fulfilled the 
inclusion criteria. Table 1 shows the demographic and 
clinical features of the study cohort. As can be seen, the 
means (SD) of age, BMI, and systolic/diastolic blood 
pressure were 59.3 (11.8) years, 23.1 (3.6) kg/m2, 127.4 
(18.4)/76.0(12.5) mmHg, respectively. 48% subjects 
received curative treatment, 34.3% subjects had local 
invasive, and more than 80% subjects with ECOG <=1.  
Quality of life in cancer patients with/without qi 
deficiency and with/without CRF
Table 2 displays the WHO-QOL scores among 
patients with/without Qi deficiency and those 
with/without CRF. As can be seen, there were 
significant differences in WHO-QOL scores in physical, 
psychological, and social domains.
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Table 1. Demographic and clinical features of cancer patients.
 N = 198
Basic data (Mean ± SD)
   Age (years)  59.3 ± 11.8
   Height (cm) 160.3 ± 7.3
   Weight (kg) 59.2 ± 11.2
   BMI (kg/m2) 23.1 ± 3.6
   SBP (mmHg) 127.4 ± 18.4
   DBP (mmHg) 76.0 ± 12.5
Sex (n,%)
   Male  72 (36.4)
   Female 126 (63.6)
Educational status (n,%)
   Illiterate  5 (2.5)
   Primary education 40 (20.2)
   Secondary education 85 (42.9)
   Tertiary education   68 (34.3)
Religious affiliations (n,%)
   None  27 (13.6)
   Christianity  30 (15.2)
   Buddhist  82 (41.4)
   Taoist and traditional beliefs  53 (26.8)
   Others  6 (3)
Therapy (n,%)
   Curative treatment  95 (48)
   Palliative treatment  14 (7.1)
   Follow-up after curative treatment  89 (44.9)
Disease status (n,%)
   Non-symptomatic 35 (17.7)
   Local 68 (34.3)
   Regional  55 (27.8)
   Metastases  39 (19.7)
   End stage 1 (0.5)
ECOG PSR (n,%)
   0 (Normal)  46 (23.2)
   1 (Some symptoms) 120 (60.6)
   2 (Confined to bed < 50%)  29 (14.6)
   3 (Confined to bed > 50%) 3 (1.5)
   4 (Unable to get out of bed) 0 (0)
Cancer diagnosis (n,%)
   GI tract  57 (28.8)
   Breast  60 (30.3)
   Lung  19 (9.6)
   Head & Neck  20 (13.1)
   GU&GYN 23 (11.6)
   Others  13 (6.6)
BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic 
Blood Pressure; ECOG PSR , Eastern Cooperative Oncology Group 
performance status rating; GU&GYN , Genitourinary Cancer & 
Gynecologic Cancer 
Table 2. Demographic characteristics and WHO-QOL scores of Cancer Patients with/without Qi Deficiency and those with/without cancer-related 
fatigue
Qi Deficiency Cancer-related fatigue
Variable With (n = 94) Without (n = 104) P With (n = 25) Without (n = 173) P
Characteristics
      Male/Female 35/59 37/67 0.883 7/18 65/108 0.385
      Age (years) 60.6 ± 11.7 58.1 ± 11.8 0.141 57.4 ± 11.2 59.6 ± 11.9 0.391
      BMI (kg/m2) 22.6 ± 3.6 23.4 ± 3.7 0.155 22.7 ± 3.3 23.1 ± 3.7 0.563
      SBP (mmHg) 128.2 ± 18.7 126.6 ± 18.2 0.588 130.6 ± 8.1 126.9 ± 18.5 0.369
      DBP (mmHg) 77.1 ± 13.1 75.0 ± 12.0 0.260 79.4 ± 11.3 75.5 ± 12.7 0.172
WHO-QoL
      Physical 53.5 ± 18.2 68.3 ± 15.0 < 0.001 44.0 ± 17.9 64.4 ± 16.4 < 0.001
      Psychological 61.9 ± 19.1 76.5 ± 13.7 < 0.001 51.8 ± 18.7 72.7 ± 15.9 < 0.001
      Social 65.5 ± 20.6 77.3 ± 12.8 < 0.001 58.2 ± 21.5 74.3 ± 16.1 0.001
      Environmental 68.0 ± 17.0 78.6 ± 11.0 < 0.001 62.6 ± 17.7 75.6 ±13.7 < 0.001
BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; WHO-Qol, World Health Organization Quality of Life short-
form (WHOQoL-BREF) questionnaire
Data are presented as mean ± SD. 
Table 3 shows the correlation between patients with/
without qi deficiency and those with/without CRF. As 
can be seen, the correlation is significant at p < 0.001, 
indicating the existence of an association between the 
two groups. All patients diagnosed with Qi deficiency 
also had CRF present. In addition, there was still 39.9% 
(69/173) of Qi-deficient patients in the group diagnosed 
with cancer having no CRF.
Quality of life in no-CRF cancer patients with and 
without Qi deficiency 
Table 4 shows the demographic characteristics and 
WHO-QOL scores of the 173 no-CRF cancer patients 
with and without Qi deficiency. As can be seen, there 
were significant differences in WHO-QOL scores in 
physical, psychological, and social domains between 
patients with and without Qi deficiency. Qi-deficient 
cancer patients, even without CRF, had significantly 
lower WHO-QOL scores. In other words, despite of not 
suffering from CRF, cancer patients with Qi deficiency 
have poorer quality of life.
Quality of life in patients with neither Qi deficiency 
nor CRF, Qi deficiency only, and both
Table 5 shows the demographic characteristics and 
WHO-QOL scores of patients with neither Qi deficiency 
nor CRF, Qi deficiency only, and both. As can be seen, 
there were significant differences in WHO-QOL scores 
in physical, psychological, and social domains in all 
three groups of patients. Among them, cancer patients 
with both Qi deficiency and CRF have the lowest WHO-
QOL scores, followed by those with Qi deficiency. 
Cancer patients with neither Qi deficiency nor CRF have 
the highest WHO-QOL scores.
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Discussion
CRF is the most prevalent symptom in cancer 
patients (Wagner and Cella, 2004). CRF is a clinical 
manifestation, and different definition and measurement 
have different prevalence in many previous studies 
(Campos et al., 2011; de John et al., 2004; Irvine et 
al., 1994; Molassiotis and Chan, 2004). In this study, 
we adopted the ICD-10 criteria for diagnosing CRF. 
Cancer patients are diagnosed as suffering from CRF 
if they have felt lack of energy, or an increased need 
to rest for at least 2 weeks over the last month, and 
have experienced more than 5 of the 10 common 
clinical sensations (generalized weakness, diminished 
concentration, decreased motivation, insomnia, 
experience of sleep as un-refreshing, perceived need 
to struggle to overcome inactivity, marked emotional 
reactivity (e.g., sadness, frustration, or irritability) 
to feeling fatigued, difficulty completing daily tasks 
attributed to feeling fatigued, perceived problems 
with short-term memory, and post-exertional malaise 
lasting several hours). Using the ICD-10 CRF diagnosis 
criteria, Cella et al. found fatigue presented in 17% of 
cancer patients receiving chemotherapy or radiation 
therapy while Sadler et al. reported 21% of patients 
undergoing blood or bone marrow transplantation 
having fatigue (Cella et al., 2001; Sadler et al., 2002). In 
the present study, only 12.6% (25/198) of our subjects 
were diagnosed with CRF. The relatively low percentage 
of patients with CRF may be attributed to the majority 
of patients (166, 82.3%, Table 1) having mild symptoms 
with ECOG PSR l 1. 
In TCM, Qi is the vital energy that maintains blood 
circulation, warms the body and fights diseases. 
From our clinical experiences and description in old 
book of Chinese medicine, severe Qi deficiency is 
prevalent among cancer patients during treatment or 
even long after treatment, thus affecting their QOL. 
To our knowledge, there was currently no diagnostic 
or screening tool for detecting Qi deficiency in cancer 
patients. Hence, we attempted to develop a simple 
tool or questionnaire for screening patients with Qi 
deficiency according to the concept of TCM and our 
clinical experiences.
In this study, 47.5% (94/198) of the subjects were 
diagnosed with Qi deficiency while only 12.6% (25/198) 
of the subjects were diagnosed with CRF. Both of these 
two groups had low QOL scores. In addition, all patients 
diagnosed with CRF had Qi deficiency while 39.9% 
(69/173) of patients with Qi deficiency were diagnosed 
as having no CFR. From the clinical perspective of 
health care provision, regardless of whether cancer 
patients had CRF, Qi deficiency or other discomfort 
sensations, these symptoms should be taken into 
consideration. The present results showed that cancer 
patients with CRF and Qi deficiency had low QOL 
scores and greater attention should be given to them by 
the health care team for cancer patients. As mentioned, 
among those not present with CRF, there was 39.9% 
Table 3. Correlations between Cancer Patients with/without Qi 
deficiency and those with/without cancer-related fatigue
Cancer-related fatigue
Qi Deficiency
With (%) Without (%) P
  With  (n = 25) 25 (100) 0 (0)
< 0.001
Without (n = 173) 69 (39.9) 104 (60.1)
Table 4. Demographic Characteristics and WHO-QOL scores of No-
cancer-related fatigue Cancer Patients with and without Qi Deficiency
 Qi Deficiency 
Variables With (n = 69)
Without
(n =104) P
Characteristics
Male/Female (no.) 28/41 37/67 0.525
      Age (years) 61.8 ± 11.8 58.1 ± 11.8 0.049
      BMI (kg/m2) 22.6 ± 3.8 23.4 ± 3.7 0.203
      SBP (mmHg) 127.3 ± 19.0 126.6 ± 18.2 0.843
      DBP (mmHg) 76.3 ± 13.7 75.0 ± 12.0 0.533
WHO-QoL
      Physical 58.0 ± 16.7 68.3 ± 15.0 < 0.001
      Psychological 66.4 ± 17.5 76.5 ± 13.7 0.001
      Social  69.0 ± 19.4 77.3 ± 12.8 0.008
      Environmental 70.5 ± 16.2 78.6 ± 11.0 0.002
BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic 
Blood Pressure; WHO-QoL, World Health Organization Quality of 
Life short-form (WHOQoL-BREF) questionnaire
Data are presented as mean ± SD.
Table 5. Demographic characteristics and WHO-QOL scores of 
patients with neither Qi deficiency nor cancer-related fatigue, Qi 
deficiency only, and both
Variables Neither  (n = 104)
Qi Deficiency 
Only (n = 69)
Both 
(n = 25)
Characteristics
Male/Female (no.) 37/67 28/41 7/18
Age (years) 58.1 ± 11.8 61.8 ± 11.8 57.4 ± 11.2
BMI (kg/m2) 23.4 ± 3.7 22.6 ± 3.8 22.7 ± 3.3
SBP (mmHg) 126.6 ± 18.2 127.3 ± 19.0 130.6 ± 18.1
DBP (mmHg) 75.0 ± 12.0 76.3 ± 13.7 79.4 ± 11.3
WHO-QOL
Physical 68.3 ± 15.0 58.0 ± 16.7† 44.0 ± 17.9†‡
Psychological 76.5 ± 13.7 66.4 ± 17.5† 51.8 ± 18.7†‡
Social  77.3 ± 12.8 69.0 ± 19.4† 58.2 ± 21.5†‡
Environmental 78.6 ± 11.0 70.5 ± 16.2† 62.6 ±17.7†
BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic 
Blood Pressure; WHO-QoL, World Health Organization Quality of 
Life short-form (WHOQoL-BREF) questionnaire
Data are presented as mean ± SD.
†P < 0.05 vs. Neither group.
‡P < 0.05
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(69/173) with Qi deficiency, who had poor QOL and 
needed extra clinical care. In view of this, Qi deficiency 
can serve alone or in addition to CRF as an indicator for 
care required and attention needed.
As seen in Table 5, there was a statistically significant 
trend of poor QOL in physical, psychological and 
social domains with the diagnosis among neither, only 
qi deficiency and both qi deficiency and CRF groups, 
compared to the group with neither qi deficiency 
nor CRF. Among them, cancer patients with both Qi 
deficiency and CRF have the lowest WHO-QOL scores, 
followed by those with Qi deficiency. Cancer patients 
with neither Qi deficiency nor CRF have the highest 
WHO-QOL scores. The initial findings suggested 
that Qi diagnosis method might help in examining 
the different levels of QOL for cancer patients. Many 
reports showed that improvement in Qi flow have 
beneficial effects on cancer patients (Chui et al., 2005; 
Li et al., 2007; Li et al., 2008; Qi et al., 2010; Sang et 
al., 2004; Seki et al., 2005; Yan et al., 2008; Yan et al., 
2010) with different mechanisms involved (Greenwood, 
1999; Lu and Li, 2009; Wang et al., 2010; Zhang et al., 
2006). Further in vivo and in vitro studies are needed to 
explore this.  
A limitation of this study is that only three questions 
were designed for diagnosing or screening Qi deficiency, 
which may result in false positive or overestimation. 
Whether more questions should be included remains 
inconclusive. Nevertheless, this study proves that the 
three questions designed have provided an easy and 
quick screening tool for patients having Qi deficiency 
with valid differentiation results.
In summary, the present study showed statistically 
significant difference in WHO-QOL scores in physical, 
psychological, and social domains between the groups 
with and without Qi deficiency as well as the groups 
with and without CRF. Cancer patients diagnosed with 
Qi deficiency or CRF have poor QOL. The concept 
of Qi deficiency in TCM might be applied to cancer 
health care. Related studies are worth more in-depth 
investigation in future.
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